ABSTRACT
In December 2019, a coronavirus 2019 (COVID-19) disease outbreak occurred in Wuhan, China, and rapidly spread to other areas worldwide. Although diffuse alveolar damage and acute respiratory failure were the main features, the involvement of other organs needs to be explored. We conducted the review to evaluate the latest evidence on the association between cerebrovascular, cardiovascular and kidney disease, and poor outcome in patients with coronavirus disease 2019 (COVID-19) pneumonia. Cardiovascular, cerebrovascular and kidney disease was associated with increased mortality and borderline increase in severity of COVID-19. Gender, age, hypertension, diabetes, and respiratory comorbidities did not influence the association. © 2020, Colegio Mexicano de Anestesiologia A.C.. All rights reserved.